tripelennamine has been researched along with Dementia Praecox in 2 studies
Tripelennamine: A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| STEVENS, JD | 1 |
| Addington, J | 1 |
| el-Guebaly, N | 1 |
2 other studies available for tripelennamine and Dementia Praecox
| Article | Year |
|---|---|
Dual function of psychotherapeutic antihistamine (tranquilizer-antiallergic) in schizophrenia.
Topics: Anti-Allergic Agents; Histamine H1 Antagonists; Hypnotics and Sedatives; Psychotropic Drugs; Schizop | 1962 |
Intravenous tripelennamine abuse in schizophrenia.
Topics: Adult; Diagnosis, Dual (Psychiatry); Histamine H1 Antagonists; Humans; Male; Middle Aged; Patient Ad | 1996 |